These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6432116)

  • 1. Graves' disease and atrial fibrillation: the case for even higher doses of therapeutic iodine-131.
    Scott GR; Forfar JC; Toft AD
    Br Med J (Clin Res Ed); 1984 Aug; 289(6442):399-400. PubMed ID: 6432116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease).
    Ursu HI; Dumitriu L; Grigorie D; Simescu M; Vaida E; Belgun M; Popovici D
    Rom J Endocrinol; 1993; 31(3-4):155-63. PubMed ID: 7697064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversion of thyrotoxic atrial fibrillation in hypothyroid state after radioiodine treatment.
    Yamamoto M; Saito S; Sakurada T; Yoshida K; Kaise K; Kaise N; Fukazawa H; Itagaki Y; Yoshinaga K
    Endocrinol Jpn; 1992 Jun; 39(3):223-8. PubMed ID: 1425447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India.
    Sankar R; Sekhri T; Sripathy G; Walia RP; Jain SK
    J Assoc Physicians India; 2005 Jul; 53():603-6. PubMed ID: 16190128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK; Larsen PR
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study.
    Howarth D; Epstein M; Lan L; Tan P; Booker J
    Eur J Nucl Med; 2001 Oct; 28(10):1489-95. PubMed ID: 11685491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs.
    Esfahani AF; Kakhki VR; Fallahi B; Eftekhari M; Beiki D; Saghari M; Takavar A
    Hell J Nucl Med; 2005; 8(3):158-61. PubMed ID: 16390021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose 131I in treatment of Graves' disease.
    Lowdell CP; Dobbs HJ; Spathis GS; McCready VR; Cosgrove DO; Harmer CL
    J R Soc Med; 1985 Mar; 78(3):197-202. PubMed ID: 3838347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized comparison of radioiodine doses in Graves' hyperthyroidism.
    Leslie WD; Ward L; Salamon EA; Ludwig S; Rowe RC; Cowden EA
    J Clin Endocrinol Metab; 2003 Mar; 88(3):978-83. PubMed ID: 12629071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration.
    Calegaro JU; De Freitas Gomes E; Bae SH; Ulyssea R; Casulari LA
    Panminerva Med; 2000 Dec; 42(4):241-5. PubMed ID: 11294085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome.
    Reinhardt MJ; Brink I; Joe AY; Von Mallek D; Ezziddin S; Palmedo H; Krause TM
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1118-24. PubMed ID: 12192554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose radioiodine given six-monthly in Graves' disease.
    Hoskin PJ; Spathis GS; McCready VR; Cosgrove DO; Harmer CL
    J R Soc Med; 1985 Nov; 78(11):893-8. PubMed ID: 3840844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of radioiodine doses for 6-hr and 24-hour iodine-131 thyroid uptake values for Graves' hyperthyroidism.
    Horn-Lodewyk J
    Endocr J; 2019 Dec; 66(12):1047-1052. PubMed ID: 31391354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid echogenicity predicts outcome of radioiodine therapy in patients with Graves' disease.
    Markovic V; Eterovic D
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3547-52. PubMed ID: 17609305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome following standardized 185 MBq dose 131I therapy for Graves' disease.
    Watson AB; Brownlie BE; Frampton CM; Turner JG; Rogers TG
    Clin Endocrinol (Oxf); 1988 May; 28(5):487-96. PubMed ID: 3214941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioiodine (131I) therapy of Graves' disease: use of the new high resolutional ultrasonic scanner for the determination of the accurate weight of the thyroid gland.
    Nagayama Y; Ashizawa K; Matsuo K; Inoue S; Harakawa S; Hirayu H; Yamashita S; Izumi M; Nagataki S
    Endocrinol Jpn; 1989 Jun; 36(3):359-65. PubMed ID: 2684619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.